openPR Logo
Press release

Autologous Fat Grafting to be The New Horizon of Aesthetic Medicine, finds FactMR study

07-09-2019 02:39 PM CET | Industry, Real Estate & Construction

Press release from: Fact.MR

Autologous Fat Grafting to be The New Horizon of Aesthetic

According to a new study of FactMR, the autologous fat grafting market reached ~US$ 320 Mn in 2018, and is estimated to record ~14% Y-o-Y in 2019.   Autologous fat grafting continues to gain popularity as an effective solution for various volume filling applications, despite lack of standardized guidelines for harvesting, processing and implementation. Leading players in the autologous fat grafting market are putting efforts for discovering ideal methodology for the process, considering patient-related aspects while formulating strategies.

The study opines that autologous fat grafting will be the next frontier in the aesthetic medicine landscape, gaining widespread acceptance as an efficient method to satisfy patient requirement for larger volume loss cost-effectively. Comprehensive solutions have been introduced by stakeholders in the autologous fat grafting market, which enable achieving consistency in the high fat viability, even as maximizing the longevity of fat transfer results.

Request For a Free Sample Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=2701

The primary reason behind the fact that autologous fat grafting is being touted as the next step in aesthetic medicine, is the opportunity offered to physicians to be on the forefront of aesthetic medicine. This has further paved novel methods and revenue streams for physicians in their practice. Autologous fat grafting will continue to gain momentum as a cost-effective and relatively better solution to achieve fat reduction in body contouring procedures.

Gains Remain High from Use in Breast Augmentation

The study opines that increasing traction of autologous fat grafting as a promising method for breast augmentation, continues to expand the bandwidth of opportunities for the stakeholders in the development of products and accessories. Gains from autologous fat grafting used for breast augmentation will account for ~50% market shares in 2019. Autologous fat grafting is emerging as a promising and safer alternative to breast augmentation procedures. Key players in the market are leveraging mergers and acquisitions based strategies to gain a strong hold in the market. For instance, in June 2019, Innova Medical partnered with Medical Device Resource Corporation to present their plastic and cosmetic surgery customers with holistic and diverse autologous fat grafting product options.

Request Our Report Methodology - https://www.factmr.com/connectus/sample?flag=RM&rep_id=2701

Sensing varied requirements of autologous fat grafting procedure, a range of products have been developed and introduced to the market, which range from accessories and integrated fat transfer systems, to fat processing systems. Demand for accessories continue to grow at a relatively faster rate, with sales estimated to account for ~60% shares in 2019 and the foreseeable future. Fat harvesting cannulas will remain the top-selling accessory of autologous fat grafting, with sales estimated to record ~20% Y-o-Y in 2019 over 2018.

According to the study, North America will remain the leading market for autologous fat grafting, accounting for ~40% share in 2019. Favorable reimbursement policies apropos of the dermatology procedures and aesthetic medicine continue to augur well for growth of the autologous fat grafting market in North America. Promising areas of research in the autologous fat grafting have come to the fore, with targeted experiments on tissue engineering constructs, ASC culture and expansion, converging with the clinical reconstructive processes.

Growing adoption of integrated fat transfer systems to remove local deposits of excess fat via minimal incision, and for transferring the tissue back to the patient, have significantly driven the demand for integrated fat transfer systems. Additionally, there has been a notable rise in the use of liposuction systems in autologous fat grafting, owing to their ability to effectively reduce surgeon fatigue, while offering a safer and more precise solution that results in faster recovery for patients.

To Buy Report, Visit - https://www.factmr.com/checkout/2701/S

This study offers a long-term outlook of the autologous fat grafting market for the period, 2019 to 2029. The autologous fat grafting market is projected to register ~14% CAGR through 2029.

Contact Us

FactMR
11140 Rockville Pike
Suite 400, Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autologous Fat Grafting to be The New Horizon of Aesthetic Medicine, finds FactMR study here

News-ID: 1800148 • Views: 135

More Releases from Fact.MR

01-21-2021 | Health & Medicine
Fact.MR
Behavioural Health Treatment Market Share, Size & Trend | Industry Analysis Repo …
Burden of mental illness on Europe’s economy is among the largest in the world, inadvertently making it the most lucrative region for players in the behavioural health treatment market, with the region slated to account for a staggering 47% of the global market by 2027. Total cost associated with mental health treatment amounted to around US$ 668 Bn in 2018 across the EU, translating to 4% of the GDP of
01-21-2021 | Health & Medicine
Fact.MR
Cancer Immunotherapy Market is predicted to grow at a staggering CAGR of 15 % fr …
A recent report published by Fact.MR points towards disequilibrium in the distribution of cancer immunotherapy in developing and developed regions. In the U.S., high frequency of knowledge-based awareness campaigns encourages individuals to undergo cancer diagnostics, and government-led insurance plans cover high treatment spending. Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4367 In stark contrast, developing countries such as Brazil and Argentina lack primary cancer treatment tools. A similar scenario
01-21-2021 | Health & Medicine
Fact.MR
Basal Cell Carcinoma Treatment Market to grow at a CAGR of 9 % over the forecast …
Surgical treatment dominates with the highest revenue amongst all treatment options in the basal cell carcinoma treatment market, with a projected value of US$ 6 billion by the end of 2025. Mohs surgery is found to be an effective treatment for basal cell carcinoma (BCC), whereas, surgical excision accounts for the highest revenue amongst surgical treatment types. Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4366 Companies in the basal
01-21-2021 | Health & Medicine
Fact.MR
Medical Marker Bands Market: Opportunities and Forecast Assessment, 2019-2029 | …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On

All 5 Releases


More Releases for Autologous

Autologous Matrix-induced Chondrogenesis Market: Report Scope and Market Segment …
The global autologous matrix-induced chondrogenesis (AMIC) market has been expected in a publication prepared by Transparency Market Research (TMR) to witness strategies aimed toward business expansion in developing economies. Countries such as South Africa, Mexico, China, India, and Brazil could be focused upon by AMIC players for gaining a strategic position in the market. This has been anticipated to help companies reduce their AMIC product costs supported by the hiring
Autologous Matrix-induced Chondrogenesis Market : Share and Analysis To 2025
Global Autologous Matrix-induced Chondrogenesis Market: Overview Autologous matrix-induced chondrogenesis (AMIC) refers to a type of treatment for the damage of articular cartilage. The treatment blends the application of a bi-layer collagen I/III membrane with micro fracture surgery. The treatment refers to a single step procedure that makes use of micro fracturing method and that is a well-established first line of treatment. The world AMIC market is foreseen to grow owing to the
Autologous Matrix-Induced Chondrogenesis Market Estimated to Flourish by 2024
Autologous Matrix-Induced Chondrogenesis (AMIC) is a biological treatment method to repair articular cartilage damage. AMIC therapy is a step wise process. Micro fracture surgery is followed by application of a bi-layer collagen I/III membrane. It slows down cartilage degeneration with an intent to avoid or delay partial or total joint replacement (e.g. knee replacement) surgery. The indications for AMIC includes Grade III or IV chondral lesions with lesion size of
Autologous Matrix-induced Chondrogenesis Market Research Report Forecast to 2024
The global AMIC market to rise at a CAGR of 8.6% between 2016 and 2024 to achieve a revenue valuation of US$186.38 mn by the concluding forecast year. In 2015, the market had reached a US$89.71 mn. By material, the AMIC market for collagen could attain a higher share of almost 50.0% by 2024. Calculated to develop at an 8.3% CAGR, North America has been predicted to be a highly
Autologous Cell Therapy Market : Trend, Analysis
Global Autologous Cell Therapy Market: Overview Autologous cell therapy refers to infusion or transfer of human tissue or cells back to the same person for treating a diseased part. For the same purpose, stem cells are removed from the patient, harvested, cultured, and once again transplanted to the same person. The purpose of this method is to reduce the chances of rejection to the treatment by the body. Furthermore, autologous cell
Autologous Cell Therapy Market: High Prevalence of Cancer Triggers Demand for Au …
Global Autologous Cell Therapy Market: Overview Autologous cell therapy refers to infusion or transfer of human tissue or cells back to the same person for treating a diseased part. For the same purpose, stem cells are removed from the patient, harvested, cultured, and once again transplanted to the same person. The purpose of this method is to reduce the chances of rejection to the treatment by the body. Furthermore, autologous cell